Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs

Abstract Background The duration of treatment (DOT) of the initial intervention and subsequent treatment is the key to determining the accuracy of anticancer-drug budget impact analysis (BIA) calculations. However, existing studies only use simple assumptions as a proxy for DOT, resulting in a high...

Full description

Bibliographic Details
Main Authors: Yue Ma, Jiting Zhou, Yuxin Ye, Aixia Ma, Hongchao Li
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Online Access:https://doi.org/10.1186/s12962-023-00447-7